the journal of Pharmacy Technology the journal of Pharmacy Technology
Abstracts of Back Issues
Home
Home
Back Issues
Author Information
PharmaCE
Acknowledgments
About the journal
Order Form
Customer Service
Advertising Information
Contact Information


OLANZAPINE-INDUCED DEPRESSION
Conrad M Swartz

To request full article click here.

OBJECTIVE: To report apathetic and hypoactive depression caused by olanzapine.

CASE SUMMARY: A 29-year-old white man and a 29-year-old white woman developed apathy, hypoactivity, blunted affect, depressed mood, and other depressive symptoms while taking olanzapine. Both showed a distinctly abnormal appearance. Clinicians attributed these symptoms to psychiatric illness, but the symptoms disappeared rapidly after drug discontinuation or dose decrease.

DISCUSSION: The only previous report of depression from olanzapine involved a medication interaction with fluoxetine. Another report described olanzapine-induced orbital-frontal syndrome, with childlike oversimplicity. If such symptoms are observed, the discontinuation of olanzapine is recommended.

CONCLUSIONS: These observations suggest additional cautions when olanzapine is used outside of schizophrenia.

J Pharm Technol 2002;18:321-3.

To request full article click here.


Harvey Whitney Books


Harvey Whitney Books

 
 

the journal of Pharmacy Technology
is published by HARVEY WHITNEY BOOKS COMPANY
8044 Montgomery Road, Suite 415, Cincinnati, OH 45236-2919
P.O. Box 42696, Cincinnati, OH 45242-0696 USA
Tel. 513/793-3555, FAX 513/793-3600
Office Hours: 9-5 E.S.T.
Contact Information
All Rights Reserved. Copyright © 1998-